How do you pay?

How to pay the least

Ask for the cash price

Idhifa

We didn’t find one.

  1. Ask your pharmacy for Idhifa’s cash price, and one or two other pharmacies too.
  2. Idhifa’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Bristol Myers Squibb Patient Assistance Foundation (BMSPAF). Or call 1-800-736-0003.

See if you qualify 

Compare every option

Question
Brand nameIdhifa
Authorized genericenasidenib
Regular genericenasidenib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Idhifa?
The original
–
–

Brand nameThe maker’s card

BMS Access Support Co-Pay Assistance Program

Savings card from Bristol Myers Squibb

No insuranceNeeds insuranceNo cash price listed.
Insurance $0 a month

Sign up on bmsaccesssupport.com 

Or call 1-800-861-0048.

In the maker’s words

“$0 Co-pay per one-month supply…”

From the maker’s offer on bmsaccesssupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Idhifa itself, from the same company, sold without the brand name, and usually for less. For now Idhifa is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

IDHIFA is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test.

Source: the FDA label for Idhifa (Celgene Corporation), January 16, 2025. Full label on DailyMed 

Good to know